Jefferies Initiates ProQR Therapeutics With Outperform By: Benzinga via Benzinga October 13, 2014 at 08:04 AM EDT Analysts at Jefferies initiated coverage on shares of ProQR Therapeutics (NASDAQ: PRQR) with a Outperform rating. The target price ... Read More >> Related Stocks: Proqr Therapeutics